Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer

被引：0
|
作者：
Mikihiro Kusama
Tadashi Nomizu
Kenjiro Aogi
Masataka Yoshimoto
Noboru Horikoshi
Toshio Tabei
Shinzaburo Noguchi
Shigeto Miura
Norio Yoshimura
Morihiko Kimura
Kazushige Toyama
Eisei Shin
机构：
[1] Tokyo Medical University,
[2] Hoshi General Hospital,undefined
[3] National Hospital Shikoku Cancer Center,undefined
[4] Cancer Institute Hospital,undefined
[5] Japanese Foundation for Cancer Research,undefined
[6] Saitama Prefectural Cancer Center,undefined
[7] Osaka University,undefined
[8] Aichi Prefecture Cancer Center,undefined
[9] Kyoto Prefectural University,undefined
[10] Gunma Prefecture Cancer Center,undefined
[11] Shizuoka Prefecture General Hospital,undefined
[12] National Osaka Hospital,undefined
[13] Sinjyuku Breast Center Kusama Clinic,undefined
[14] International University of Health and Welfare,undefined
[15] Mita Hospital,undefined
[16] Juntendo University School of Medicine,undefined
[17] Kamiiida Daiichi General Hospital,undefined
[18] Ohta General Hospital,undefined
[19] Shizuoka Health Management Center,undefined
[20] Iseikai Hospital,undefined
来源：
Breast Cancer | 2010年 / 17卷
关键词：
Capecitabine; Breast cancer; Advanced; Metastatic; Efficacy; Safety; Four-week (Japanese) regimen;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：233 / 240
页数：7
相关论文
共 50 条
  • [1] Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer
    Kusama, Mikihiro
    Nomizu, Tadashi
    Aogi, Kenjiro
    Yoshimoto, Masataka
    Horikoshi, Noboru
    Tabei, Toshio
    Noguchi, Shinzaburo
    Miura, Shigeto
    Yoshimura, Norio
    Kimura, Morihiko
    Toyama, Kazushige
    Shin, Eisei
    BREAST CANCER, 2010, 17 (04) : 233 - 240
  • [2] Phase II study of weekly docetaxel and capecitabine in patients with metastatic breast cancer
    Mrozek, Ewa
    Ramaswamy, Bhuvaneswari
    Young, Donn
    Rhoades, Chris A.
    Kendra, Kari
    Allen, Joan
    Moore, Tim
    Hauger, Marsha
    Watson, Holly
    Merriman, Nancy
    Nadella, Padma
    Villalona-Calero, Miguel
    Shapiro, Charles L.
    CLINICAL BREAST CANCER, 2006, 7 (02) : 141 - 145
  • [3] Impact of 4-weekly capecitabine plus paclitaxel (XP) combination therapy for metastatic breast cancer: a multicenter phase II trial (KBCSG-0609)
    Yamamoto, D.
    Taguchi, T.
    Masuda, N.
    Nakayama, T.
    Nagata, T.
    Nomura, M.
    Yoshidome, K.
    Yoshino, H.
    Sakamoto, J.
    Noguchi, S.
    EJC SUPPLEMENTS, 2010, 8 (03): : 201 - 201
  • [4] Phase II Study of Weekly Paclitaxel for Advanced or Metastatic Breast Cancer in Japan
    Horiguchi, Jun
    Rai, Yoshiaki
    Tamura, Kazuo
    Taki, Toshihiko
    Hisamatsu, Kazufumi
    Ito, Yoshinori
    Seriu, Taku
    Tajima, Tomoo
    ANTICANCER RESEARCH, 2009, 29 (02) : 625 - 630
  • [5] A phase II study of capecitabine and weekly docetaxel combination chemotherapy in patients with metastatic breast cancer.
    Puglisi, F
    Scalone, S
    Minisini, AM
    Mansutti, M
    Crivellari, D
    Buonadonna, A
    Zanetti, M
    Ermacora, P
    Piga, A
    Veronesi, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 78S - 78S
  • [6] Weekly docetaxel and capecitabine in the treatment of advanced gastric cancer: A phase II study
    Orditura, M.
    Aurilio, G.
    Galizia, G.
    Carlomagno, C.
    Lieto, E.
    Vecchione, L.
    Martinelli, E.
    De Placido, S.
    Catalano, G.
    Ciardiello, F.
    De Vita, F.
    ANNALS OF ONCOLOGY, 2006, 17 : XI52 - XI52
  • [7] Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients
    Li, Wenhua
    Xu, Jianming
    Shen, Lin
    Liu, Tianshu
    Guo, Weijian
    Zhang, Wen
    Chen, Zhiyu
    Zhu, Xiaodong
    Li, Jin
    BMC CANCER, 2014, 14
  • [8] Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients
    Wenhua Li
    Jianming Xu
    Lin Shen
    Tianshu Liu
    Weijian Guo
    Wen Zhang
    Zhiyu Chen
    Xiaodong Zhu
    Jin Li
    BMC Cancer, 14
  • [9] Phase II study of weekly docetaxel and capecitabine in patients with metastatic gastric cancer (GC).
    Catalano, G
    Orditura, M
    Diadema, MR
    Aurilio, G
    Ciardiello, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 359S - 359S
  • [10] Weekly docetaxel and capecitabine is not effective in the treatment of advanced gastric cancer: a phase II study
    Orditura, M.
    Martinelli, E.
    Galizia, G.
    Carlomagno, C.
    Aurilio, G.
    Vecchione, L.
    Lieto, Eva
    De Placido, S.
    Catalano, G.
    Ciardiello, F.
    De Vita, F.
    ANNALS OF ONCOLOGY, 2006, 17 (10) : 1529 - 1532
12345